Management of acute exacerbations of chronic obstructive pulmonary disease: A summary and appraisal of published evidence

Annals of Internal Medicine

Volumn 134, Issue 7, 2001, Pages 600-620

  Bach, P B ^a   Brown, C ^a   Gelfand, S E ^a   McCrory, D C ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMBROXOL; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BROMHEXINE; BRONCHODILATING AGENT; CARBOCISTEINE; CHLORAMPHENICOL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; COTRIMOXAZOLE; DOMIODOL; DOXYCYCLINE; HYDROCORTISONE; METHYLPREDNISOLONE; MUCOLYTIC AGENT; OXYTETRACYCLINE; PENICILLIN G; PREDNISOLONE; PREDNISONE; STREPTOMYCIN; TETRACYCLINE;

ANTIBIOTIC THERAPY; ARTERIAL GAS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG EFFICACY; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; MORTALITY; OXYGEN THERAPY; PHYSIOTHERAPY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RELAPSE; RESPIRATORY TRACT INFECTION; REVIEW; SPIROMETRY; THORAX RADIOGRAPHY;

EID: 0035799388     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-134-7-200104030-00016     Document Type: Review

References (129)

1. Management of acute exacerbations of chronic obstructive pulmonary disease
2. Strategies in preserving lung health and preventing COPD and associated diseases. The National Lung Health Education Program (NLHEP)
3. Healthcare cost and utilization project
4. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. National Heart, Lung, and Blood Institute Workshop Summary. Bethesda, Maryland, August 29-31, 1995
5. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
6. Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
7. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
8. BTS guidelines for the management of chronic obstructive pulmonary disease
9. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD
10. Role of infection in chronic bronchitis
11. Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease
12. Interactions between viruses and bacteria in patients with chronic bronchitis
13. An analysis of decisions by European general practitioners to admit to hospital patients with lower respiratory tract infections
14. Epidemiology and treatment of chronic bronchitis and its exacerbations
15. Air pollution and hospital admissions for the elderly in Detroit, Michigan
16. Outcomes following acute exacerbation of severe chronic obstructive lung disease
17. Time course and recovety of exacerbations in patients with chronic obstructive pulmonary disease
18. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease
19. The necessary length of hospital stay for chronic pulmonary disease
20. Acute respiratory failure in chronic obstructive pulmonary disease. Immediate and long-term prognosis
21. Determinants of immediate survival among chronic respiratory insufficiency patients admitted to an intensive care unit for acute respiratory failure. A prospective multicenter study
22. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease
23. Effect of inspiratory flow rate on gas exchange during mechanical ventilation
24. Follow-up study of disability among elderly patients discharged from hospital with exacerbations of chronic bronchitis
25. Predicting future functional status for seriously ill hospitalized adults. The SUPPORT prognostic model
26. Does increased access to primary care reduce hospital readmissions?
27. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
28. Assessing the generalizability of prognostic information
29. Complaints of breathlessness in the emergency department. The experience at a community hospital
30. Use of emergency medical services by patients with decompensated obstructive lung disease
31. Spirometric criteria for hospital admission of patients with acute exacerbation of COPD
32. Treatment of decompensated chronic obstructive pulmonary disease in the emergency department - Correlation between clinical features and prognosis
33. A multivariate model for the prediction of relapse after outpatient treatment of decompensated chronic obstructive pulmonary disease
34. A multivariate model for predicting hospital admissions for patients with decompensated chronic obstructive pulmonary disease
35. Acute infective exacerbations of chronic bronchitis
36. Adult emergency visits for chronic cardiorespiratory disease: Does dyspnea matter?
37. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD
38. Acute exacerbation of COPD: Factors associated with poor treatment outcome
39. Respiratory failure revisited: Acute exacerbations of chronic bronchitis between 1961-68 and 1970-76
40. Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease: Risk factors and use of guidelines for management
41. Mortality in intensive care patients with respiratory disease. Is age important?
42. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease
43. Relation of FEV(1) to clinical outcomes during exacerbations of chronic obstructive pulmonary disease
44. Prognosis of COPD patients after an episode of acute respiratory failure
45. Acute exacerbations of chronic obstructive pulmonary disease and mechanical ventilation: A reevaluation
46. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults
47. Evaluation of high-yield criteria for chest radiography in acute exacerbation of chronic obstructive pulmonary disease
48. Routine chest radiographs in exacerbations of chronic obstructive pulmonary disease. Diagnostic value
49. Guidelines for the selective ordering of admission chest radiography in adult obstructive airway disease
50. Relationship between arterial blood gases and spirometry in acute exacerbations of chronic obstructive pulmonary disease
51. Use of peak expiratory flow rate in emergency department evaluation of acute exacerbation of chronic obstructive pulmonary disease
52. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction
53. Fenoterol and ipratropium bromide for treatment of patients with chronic bronchitis
54. A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD
55. Terbutaline vs albuterol for out-of-hospital respiratory distress: Randomized, double-blind trial
56. Effect of different albuterol dosing regimens in the treatment of acute exacerbation of chronic obstructive pulmonary disease
57. Aminophylline therapy for acute bronchospastic disease in the emergency room
58. Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. A controlled trial
59. Intravenous aminophylline in the treatment of acute bronchospastic exacerbations of chronic obstructive pulmonary disease
60. Effects of combined treatment with glycopyrrolate and albuterol in acute exacerbation of chronic obstructive pulmonary disease
61. Decreased duration of emergency department treatment of chronic obstructive pulmonary disease exacerbations with the addition of ipratropium bromide to beta-agonist therapy
62. Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease
63. Severe exacerbations of COPD and asthma. Incremental benefit of adding ipratropium to usual therapy
64. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room
65. Risk of toxicity in patients with elevated theophylline levels
66. Nebulizer vs. spacer for bronchodilator delivery in patients hospitalized for acute exacerbations of COPD
67. Terbutaline metered-dose inhalation vs meta-proterenol by hand-held nebulization: A comparison in black inner-city COPD patients
68. Changes in blood gas levels after nebuhaler and nebulizer administration of terbutaline in severe chronic airway obstruction
69. Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients
70. Comparison of a hand-held nebulizer with a metered dose inhaler-spacer combination in acute obstructive pulmonary disease
71. Metered-dose inhaler vs. compressor-driven nebulizer in the delivery of metaprotenerol
72. Aerosol bronchodilator delivery methods. Relative impact on pulmonary function and cost of respiratory care
73. Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction
74. Bronchodilator delivery in acute airflow obstruction. A meta-analysis
75. Early corticosteroid use in acute exacerbations of chronic airflow obstruction
76. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: A prospective randomised controlled trial
77. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation
78. A randomized controlled trial of methylprednisolone in the emergency treatment of acute exacerbations of COPD
79. Controlled dinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency
80. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease
81. Exacerbations of chronic bronchitis: Treatment with oxytetracycline
82. Prophylactic use of oxytetracycline for exacerbations of chronic bronchitis
83. Antibiotic regimes in chronic bronchitis
84. Amoxicillin in treatment of acute uncomplicated exacerbations of chronic bronchitis. A double-blind, placebo-controlled multicentre study in general practice
85. Antibiotic therapy of acute exacerbations of chronic bronchitis. A controlled study using tetracycline
86. A controlled study of the effect of treatment on chronic bronchitis. An evaluation using pulmonary function tests
87. Antibiotic regimens in moderately ill patients with purulent exacerbations of chronic bronchitis
88. Value of ampicillin in the hospital treatment of exacerbations of chronic bronchitis
89. Antibiotic regimens in severe and acute purulent exacerbations of chronic bronchitis
90. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice
91. Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis
92. Evaluation of an antibiotic prescribing protocol for treatment of acute exacerbations of chronic obstrucdve airways disease in a hospital respiratory unit
93. The "28 percent" Venturi mask in obstructive airway disease
94. Controlled oxygen administration in acute respiratory failure in chronic obstructive pulmonary disease: A reappraisal
95. Studies of oxygen administration in respiratory failure
96. Effect of controlled oxygen therapy on arterial blood gases in acute respiratory failure
97. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: A clinical trial
98. Clinical study on the effects of an antibiotic and mucolytic association (amoxicillin and domiodol) in hypersecretory chronic bronchopulmonary diseases
99. Double-blind clinical trial of bromhexine as a mucolytic drug in chronic bronchitis
100. Ambroxol plus amoxicillin in the treatment of exacerbations of chronic bronchitis
101. A between-patient, double-blind comparison of S-carboxymethylcysteine and bromhexine in chronic obstructive bronchitis
102. Physiotherapy and intermittent positive-pressure ventilation of chronic bronchitis
103. Inefficiency of chest percussion in the physical therapy of chronic bronchitis
104. 1 in chronic bronchitis
105. Comparison of the acute effects on gas exchange of nasal ventilation and doxapram in exacerbations of chronic obstructive pulmonary disease
106. Noninvasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease
107. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease
108. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease
109. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure
110. Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: A meta-analysis
111. Nasal ventilation vs. doxapram in the treatment of type II respiratory failure complicating chronic airflow obstruction
112. Treatment of acute respiratory failure in COPD patients with positive airway pressure via nasal mask (NPPV)
113. Non-invasive application of bilevel positive pressure to prevent endotracheal intubation in acute respiratory failure
114. Noninvasive pressure support ventilation in patients with acute respiratory failure. A randomized comparison with conventional therapy
115. Reversal of acute exacerbations of chronic obstructive lung disease by inspiratory assistance with a face mask
116. Efficacy of noninvasive positive pressure ventilation by facial and nasal mask in hypercapnic acute respiratory failure: Experience in a respiratory ward under usual care
117. Sequential use of noninvasive pressure support ventilation for acute exacerbations of COPD
118. Noninvasive nasal mask ventilation beyond the ICU for an exacerbation of chronic respiratory insufficiency
119. Acute exacerbations in severe COLD patients. Treatment using positive pressure ventilation by nasal mask
120. Comparison of nasal positive-pressure ventilation to external high- frequency oscillatory ventilation in severe COPD
121. Physiological effects and optimisation of nasal assist-control ventilation for patients with chronic obstructive pulmonary disease in respiratory failure
122. Nasal ventilation in acute exacerbations of chronic obstructive pulmonary disease: Effect of ventilator mode on arterial blood gas tensions
123. Noninvasive modalities of positive pressure ventilation improve the outcome of acute exacerbations in COLD patients
124. Noninvasive mechanical ventilation in acute respiratory failure due to chronic obstructive pulmonary disease: Correlates for success
125. Noninvasive positive pressure ventilation via face mask. First-line intervention in patients with acute hypercapnic and hypoxemic respiratory failure
126. Noninvasive ventilation